REGENEREX PHARMA INC reported a net loss of $2.5M in fiscal year 2025. This represents an increase of 28.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2025, and the quarters REGENEREX PHARMA INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RGPX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RGPX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More REGENEREX PHARMA INC financials
Frequently Asked Questions
What was REGENEREX PHARMA INC's net income in fiscal year 2025?
REGENEREX PHARMA INC reported a net loss of $2.5M in fiscal year 2025.
How fast is REGENEREX PHARMA INC's net income growing?
REGENEREX PHARMA INC (RGPX) net income rose by 28.7% year over year, from -$3.5M to -$2.5M in fiscal year 2025.
How has REGENEREX PHARMA INC's net income changed over the years?
Across the 15 fiscal years this page covers, REGENEREX PHARMA INC (RGPX) net income went from -$6K in fiscal year 2009 to -$2.5M in fiscal year 2025.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what REGENEREX PHARMA INC (RGPX) reported on that line in every period on record.